Product Information
THEO-24 ER 300 MG CAPSULE is a brand (anda) product labeled by Endo USA Inc., priced at $6.9515 per EA under NDC 52244030010. Its NADAC has been published 598 times since Jan 14, 2015.
Strength
300 mg/1
Manufacturer
Endo USA Inc.NDC
52244030010
Classification
Brand (ANDA)
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
THEOPHYLLINE ANHYDROUSApproval Type
Generic (ANDA)
FDA Application
ANDA087944On Market Since
8/25/2014
Pharmacological Classes
Price Statistics
The NADAC for THEO-24 ER 300 MG CAPSULE has been published 598 times since Jan 14, 2015, and over the history we have for it it has risen 184.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.9515 per EA |
|---|---|
| All-time high | $6.9518 (May 13, 2026) |
| All-time low | $2.4436 (Jan 14, 2015) |
| 52-week high | $6.9518 |
| 52-week low | $6.7427 |
| Median price | $4.2323 |
| Average price | $4.4931 |
| Largest weekly change | +10.0% (Jul 13, 2016) |
| Weeks tracked | 598 |
| Tracking since | Jan 14, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the theophylline anhydrous market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of THEO-24 ER 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for THEO-24 ER 300 MG CAPSULE, manufactured by Endo USA Inc., is $6.9515 per EA (NDC 52244030010), effective Jun 24, 2026.
How has the price of THEO-24 ER 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for THEO-24 ER 300 MG CAPSULE has risen 184.5%. It has been tracked across 598 weekly CMS publications since Jan 14, 2015.
What are the highest and lowest recorded NADAC prices for THEO-24 ER 300 MG CAPSULE?
Since Jan 14, 2015, the NADAC for THEO-24 ER 300 MG CAPSULE has ranged from a low of $2.4436 (Jan 14, 2015) to a high of $6.9518 (May 13, 2026), with a median of $4.2323 per EA.
Are there cheaper alternatives to THEO-24 ER 300 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of THEO-24 ER 300 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures THEO-24 ER 300 MG CAPSULE?
THEO-24 ER 300 MG CAPSULE (NDC 52244030010) is labeled by Endo USA Inc., and CMS classifies it as a brand (anda) product.
Related Drugs
Same classification